$94.7 Million is the total value of Polaris Venture Management Co. V, L.L.C.'s 9 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 10.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SELB | Selecta Biosciences, Inc. | $27,419,000 | +1.9% | 1,924,151 | 0.0% | 28.95% | +0.2% | |
| TRVN | Sell | Trevena, Inc. | $13,861,000 | -3.1% | 2,053,540 | -9.5% | 14.63% | -4.7% |
| TTOO | T2 Biosystems, Inc. | $13,579,000 | -8.2% | 1,875,524 | 0.0% | 14.34% | -9.8% | |
| GNCA | Genocea Biosciences, Inc. | $10,079,000 | +24.9% | 1,968,606 | 0.0% | 10.64% | +22.8% | |
| FATE | Fate Therapeutics, Inc. | $7,716,000 | +83.5% | 2,473,186 | 0.0% | 8.15% | +80.5% | |
| OCUL | Ocular Therapeutix, Inc. | $6,861,000 | +38.8% | 998,713 | 0.0% | 7.24% | +36.5% | |
| PULM | Pulmatrix Inc. | $5,953,000 | -15.8% | 3,607,996 | 0.0% | 6.28% | -17.2% | |
| LIFE | Atyr Pharma Inc. | $5,813,000 | +14.4% | 1,827,992 | 0.0% | 6.14% | +12.5% | |
| CERU | Cerulean Pharma Inc | $3,442,000 | -50.6% | 3,287,529 | 0.0% | 3.63% | -51.4% | |
| BINDQ | Exit | Bind Therapeutics, Inc. | $0 | – | -2,018,253 | -100.0% | -0.85% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Fate Therapeutics, Inc. | 30 | Q2 2021 | 79.2% |
| Atyr Pharma Inc. | 26 | Q3 2021 | 15.1% |
| Trevena, Inc. | 22 | Q2 2019 | 24.9% |
| Genocea Biosciences, Inc. | 21 | Q1 2019 | 32.5% |
| Selecta Biosciences, Inc. | 20 | Q1 2021 | 39.5% |
| T2 Biosystems, Inc. | 20 | Q2 2019 | 36.1% |
| Dare Bioscience, Inc. | 17 | Q3 2021 | 3.9% |
| Pulmatrix, Inc. | 16 | Q1 2019 | 15.4% |
| Cerulean Pharma Inc | 13 | Q2 2017 | 16.2% |
| Kala Pharmaceuticals, Inc. | 11 | Q1 2020 | 37.1% |
View Polaris Venture Management Co. V, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2022-03-30 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-12 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-12 |
| 13F-HR | 2020-05-14 |
| 4 | 2020-05-06 |
| 3 | 2020-04-30 |
View Polaris Venture Management Co. V, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.